NCT06175806View on ClinicalTrials.gov

Granisetron Versus Ondansetron for Nausea and Vomiting in Pediatric Age Group

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 10, 2023

Primary Completion Date

November 11, 2023

Study Completion Date

November 11, 2023

Conditions
Nausea and Vomiting in Pediatric Age Group
Interventions
DRUG

Ondansetron Oral Film

5-hydroxytryptamine (5-HT) receptor antagonist

DRUG

Granisetron Oral Liquid Product

5-hydroxytryptamine (5-HT) receptor antagonist

Trial Locations (1)

1181

Faculty of Medicine-Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06175806 - Granisetron Versus Ondansetron for Nausea and Vomiting in Pediatric Age Group | Biotech Hunter | Biotech Hunter